Consistent with these results, our data demonstrated that β6 promoted the invasiveness of cholangiocarcinoma cells by activating Rac1, as both NSC23766 and Rac1 siRNA could abolish the effect of β6. The gene discussed is RAC1; the disease is cholangiocarcinoma.